Tocilizumab in COVID-19: finding the optimal route and dose
Lancet Rheumatol
.
2020 Dec;2(12):e738-e739.
doi: 10.1016/S2665-9913(20)30334-9.
Epub 2020 Sep 17.
Authors
Siddharth Jain
1
,
Sanjay Jain
1
,
Shefali Khanna Sharma
1
Affiliation
1
Division of Clinical Immunology and Rheumatology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
PMID:
32964209
PMCID:
PMC7498201
DOI:
10.1016/S2665-9913(20)30334-9
No abstract available